Provided by Tiger Trade Technology Pte. Ltd.

iShares Core High Dividend ETF

29.81
+0.08000.27%
Post-market: 29.80-0.0100-0.03%19:59 EDT
Volume:7.58M
Turnover:225.89M
Market Cap:15.27B
PE:- -
High:29.95
Open:29.73
Low:29.72
Close:29.73
52wk High:30.13
52wk Low:23.52
Shares:512.35M
Float Shares:512.35M
Volume Ratio:1.52
T/O Rate:1.48%
Dividend:0.82
Dividend Rate:2.74%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

3 ASX Dividend Stocks With Up To 7.6% Yield

Simply Wall St.
·
Jul 10

U.S. June Non-Farm Payrolls Disappoint and Inflation Eases, Prompting Potential Revision of Overly Hawkish Rate Expectations

Deep News
·
Jul 08

New York Fed President Sees Energy Price Decline Lowering Inflation, Maintains Policy Stance

Stock News
·
Jul 08

Consumer Staples Sector Shows Resilience Amid Market Downturn, Pepsi Gains Nearly 3%

Stock News
·
Jul 07

New York Fed President Anticipates Lower Energy Costs to Help Curb Overall Inflation

Deep News
·
Jul 07

Market Sentiment Shifts from Enthusiasm to Prudence: Asian Tech Stocks Face a Samsung Earnings Test, Prompting Rotation to Financial and Defensive Sectors

Stock News
·
Jul 07

How To Earn $500 A Month From Citigroup Stock Ahead Of Q2 Earnings

Benzinga Earnings
·
Jul 06

3 ASX Dividend Stocks Yielding Up To 8%

Simply Wall St.
·
Jul 06

iShares Core High Dividend ETF announces Q2 2026 distribution of R$ 0.06 per unit

Reuters
·
Jun 23

iShares Core High Dividend ETF BDR to pay BRL 0.06 per unit dividend on June 24

Reuters
·
Jun 23

iShares Core High Dividend ETF declares monthly distribution of R$ 0.34 per unit

Reuters
·
Jun 19

iShares Core High Dividend ETF BDR sets dividend at USD 0.98 per share

Reuters
·
Jun 18

Assembly Biosciences Announces Upcoming Investor Conference Presentations

GlobeNewswire
·
May 29

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

GlobeNewswire
·
May 27

Press Release: Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Dow Jones
·
May 27

FDA approves Gilead’s Hepcludex injection to treat chronic HDV infection

TIPRANKS
·
May 23

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

GlobeNewswire
·
May 22

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

GlobeNewswire
·
May 11

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

GlobeNewswire
·
May 08

Mirum’s brelovitug succeeds in Phase 2b HDV trial

TIPRANKS
·
Apr 27